Portfolio company
Combinostics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops AI software for quantifying brain images and patient data to support clinicians in diagnosing and managing neurological disorders.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Icometrix
This company develops artificial intelligence software that quantifies brain scans to assist radiologists and neurologists in monitoring neurological disorders and informing clinical decisions.
BrainQuant
This company develops artificial intelligence software that analyses magnetic resonance imaging sequences to detect neurodegenerative diseases for medical institutions and clinical researchers.
Cercare Medical
This company develops AI-powered perfusion imaging software for CT and MRI scans to assist clinicians in diagnosing neurological conditions like stroke and oncology.
Cognimark
This company develops AI software for healthcare providers to identify early signs of cognitive decline and dementia using existing electronic health records.
Hemispheric
This company develops artificial intelligence models and platforms for decoding non-invasive brain signals to assist clinicians and researchers with neurological and psychiatric diagnoses.
Cerenion
The company develops AI-based software that monitors brain function in intensive care patients for medical professionals.
Neuronostics
The company develops an EEG-based digital biomarker platform to provide objective diagnostic and prognostic support for epilepsy to healthcare providers and pharmaceutical researchers.
Neuro Event Labs Oy
This company develops AI-driven video and audio monitoring systems for detecting and classifying epileptic seizures for neurologists and their patients.
